comparemela.com

Latest Breaking News On - Biotech city - Page 2 : comparemela.com

Crescita Reports Second Quarter 2021 Results and Provides Corporate Update

Croma-Pharma Announces 9-Country Licensing Agreement with Crescita Therapeutics for Pliaglis®

Croma-Pharma Announces 9-Country Licensing Agreement with Crescita Therapeutics for Pliaglis®
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Canada s CRE industry gets wakeup call on life sciences | RENX - Real Estate News Exchange

Canada s CRE industry gets wakeup call on life sciences | RENX - Real Estate News Exchange
renx.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renx.ca Daily Mail and Mail on Sunday newspapers.

Laval launches Phase II of its Biotech City science park project

City believes pandemic could stimulate an upswing in science research The City of Laval says it is going ahead with a second phase of its Cité de la Biotech (Biotech City) industrial science park project, which was first launched with Phase I two decades ago. Since its creation, according to the city, Biotech City has seen phenomenal growth. $1 billion in investment Based on this success, Laval says it is launching Phase II of the real estate development project with more than 100,000 square metres to become available on the current grounds of the Institut national de la recherche scientifique (INRS). The city says that Phase II of Biotech City will be ready to welcome businesses in the life sciences sector, and biomedicine in particular (vaccines, antibodies, proteins, cell therapies). Laval anticipates investments of over $1 billion and the creation of 7,500 new jobs over the next decade through this development project.

Qubec biotechnology incubator inaugurates new facilities in Laval - Lab Canada

Qubec biotechnology incubator inaugurates new facilities in Laval October 20, 2003 Laval, QC October 20, 2003 Incubator Qubec Biotechnology Innovation Centre (QBIC) officially inaugurated its new Phase 3 facilities at Biotech City of Greater Montreal today. The new facilities will occupy 28,000 sq ft and are located in the Laval Biotechnology Development Centre (CDBL), a recent addition to the INRS – Institut Armand-Frappier site in Laval. “The addition of these new laboratories and offices will enable us to better meet the needs of companies starting up in the biotechnology sector,” says Dr Jacques Gagn, chairman of QBIC’s board of directors. Canada Economic Development and Economic and Regional Development Department of Qubec each contributed C$2.9 million to finance the new facilities and QBIC’s operating expenses. The centre also benefits from the support of Laval Technopole and INRS-Institut Armand-Frappier, the founders of QBIC, as well as t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.